car t-cell cytotoxicity of solid tumors is dependent on ifnγr signaling & downstream adhesion
Published 1 year ago • 748 plays • Length 37:21Download video MP4
Download video MP3
Similar videos
-
27:28
mesothelin-specific car-t cell therapy with hla-gated safety mechanism selectively kills tumor cells
-
1:00
barriers to using car t-cells in solid tumors and strategies to overcome them
-
1:53
the application of car t-cell therapy for solid tumors
-
2:36
current challenges in targeting solid tumors with car t-cells
-
1:32
car t cell therapy explained (animation) | city of hope
-
59:27
updates in car t cell therapies
-
3:14
car t-cell therapy explained (manufacturing process & how it works)
-
0:16
label-free live cell imaging: activated t-cell killing cancer cell
-
2:53
safety and efficacy of allogenic car-t cell treatment
-
5:53
car-t cells: engineered cancer killers, mechanism of action
-
6:13
lymphoma: overview of chimeric antigen receptor (car) t cells
-
11:18
car-t cells: engineered cancer killers
-
0:48
side effects of car t-cell therapy
-
0:26
how car t-cell therapy is curing cancer
-
55:10
car-t cell therapy: now and in 2030 | laboratory medicine and pathology in individualized medicine
-
16:43
engineering better car t cells: an interview with cri star yvonne chen, phd
-
1:39
car-t therapy for lung cancer
-
0:46
how successful is car-t cell therapy?
-
1:20
what is car t-cell therapy?